The main focus of research is on early detection. Europe’s leading researchers in this tumor are working to diagnose pancreatic cancer years before symptoms appear, with a blood test.
Read more
“Results from this present study indicate that EOPC patients have unique clinical and molecular characteristics and could derive particular benefit from precision oncology-based approaches,” concl...
Read more
Dr. Kevin Doello González from the Virgen de las Nieves University Hospital in Granada and Dr. Raúl Ortiz Quesada from the University of Granada, both members of this group of scientists from ibs.GR...
Read more
El ensayo clínico en fase 1 liderado por el IDIBELL y el ICO muestra que la administración del virus VCN-01 es viable y una posible nueva herramienta en el tratamiento del cáncer de páncreas avanz...
Read more
There is evidence on the effects of diet on the risk of developing pancreatic cancer. There may be a link between pro-inflammatory diets and the possibility of developing pancreatic cancer. Although t...
Read more
The biopharmaceutical company Ability Pharmaceuticals, SL today announced the inclusion of the first patients in a phase 2b clinical trial with its novel autophagy-inducer anticancer compound ABTL0812...
Read more
Nano-based drug delivery and anti-cancer therapy have shown promise in recent years as potential novel weaponry in the current arsenal of anti-cancer technologies. Nano-driven therapeutics involves th...
Read more
The Catalan biopharmaceutical company AbilityPharma, focused on the development of innovative oral anticancer compounds, undertakes the last stage of the investment round with which this year it will ...
Read more
As a notoriously ‘silent’ disease in terms of identifiable symptoms, pancreatic cancer generally manifests itself at late and advanced stages, with only 20% of patients as candidates for curati...
Read more
The project aims to identify high-risk populations for pancreatic cancer, to include them in screening and early detection interventions so as to try to increase patients' survival rates
Read more
CNIO researchers discover that healthy cells suppress inflammation unless it is required. This finding suggests new strategies to improve the prevention of pancreatic cancer. The research is published...
Read more
Ability Pharmaceuticals, a drug development biopharmaceutical company specialized in oncology, announced today that has received orphan-drug designation (ODD) for ABTL0812 from the European Medicines ...
Read more
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
A study published in Nature Communications has identified different ri...
